TABLE 1.
Clinical cohort characteristics
| HIV+ | |||
|---|---|---|---|
| HIV− | Viremic | Virally suppressed | |
| N | 6 | 18 | 12 |
| Age | 55 (39–74) | 44 (35–62) | 59 (44–67) |
| Male sex (%) | 2 (33.3) | 11 (61.1) | 12 (100) |
| HIV parameters | |||
| Viral load (plasma) a | ‐ | 56,129 (15,090–207,526) | UD |
| Viral load (CSF) a | ‐ | 594.5 (340.3–5,973) | UD b |
| CD4 T cells (mm3) | 72.0 (5.50–185) c | 355 (239–785) d | |
| Nadir CD4 T cells (mm3) | 8.00 (2.00–72.0) c | 78.0 (54.0–161) d | |
| Current ART (%) | 0 (0%) | 12 (100%) | |
| Viral suppression (yr) e | N/A | 6.2 (2.6–9.1) | |
ART = antiretroviral therapy; CSF = cerebrospinal fluid; N/A = not applicable; UD = undetectable.
a
HIV RNA copies/ml.
b
Data missing for 4 donors.
c
Data missing for 13 donors.
d
Data missing for 1 donor.
e
Viral suppression defined by undetectable plasma viral load for >2 years (1 blip <250 HIV RNA copies/ml >6 months from death permitted).